CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-07 | Boyer David W. Chief Corp. Affairs Officer | Sale | −12,801 | $102.41 | $1.3M | 15,624 |
| 2023-02-07 | Boyer David W. Chief Corp. Affairs Officer | Sale | −11,497 | $102.42 | $1.2M | 4,127 |
| 2023-02-07 | BENEVICH ERIC Chief Commercial Officer | Sale | −2,030 | $102.29 | $208K | 19,705 |
| 2023-02-07 | BENEVICH ERIC Chief Commercial Officer | Sale | −15,360 | $102.42 | $1.6M | 33,501 |
| 2023-02-07 | ABERNETHY MATT Chief Financial Officer | Sale | −2,030 | $102.33 | $208K | 24,333 |
| 2023-02-07 | ABERNETHY MATT Chief Financial Officer | Sale | −12,807 | $102.42 | $1.3M | 35,824 |
| 2023-02-07 | ABERNETHY MATT Chief Financial Officer | Sale | −11,491 | $102.40 | $1.2M | 24,333 |
| 2023-02-06 | Cooke Julie Chief Human Resources Officer | Sale | −640 | $105.47 | $67K | 16,501 |
| 2023-02-06 | Cooke Julie Chief Human Resources Officer | Sale | −575 | $104.28 | $60K | 15,926 |
| 2023-02-06 | ROBERTS EIRY Chief Medical Officer | Sale | −1,121 | $105.80 | $119K | 27,176 |
| 2023-02-06 | Lloyd-Smith Malcolm Chief Integration Officer | Sale | −801 | $105.82 | $85K | 29,300 |
| 2023-02-06 | Lippoldt Darin Chief Legal Officer | Sale | −1,041 | $105.80 | $110K | 31,290 |
| 2023-02-06 | GORMAN KEVIN CHARLES Chief Executive Officer | Sale | −3,040 | $105.68 | $321K | 468,008 |
| 2023-02-06 | Gano Kyle Chief Business Development Off | Sale | −1,600 | $105.64 | $169K | 114,257 |
| 2023-02-06 | Boyer David W. Chief Corp. Affairs Officer | Sale | −240 | $105.61 | $25K | 4,127 |
| 2023-02-06 | BENEVICH ERIC Chief Commercial Officer | Sale | −1,280 | $105.63 | $135K | 17,879 |
| 2023-02-06 | ABERNETHY MATT Chief Financial Officer | Sale | −1,280 | $105.67 | $135K | 22,507 |
| 2023-01-31 | ROBERTS EIRY Chief Medical Officer | Sale | −1,457 | $109.99 | $160K | 26,171 |
| 2023-01-31 | Onyia Jude Chief Scientific Officer | Sale | −126 | $108.48 | $14K | 2,477 |
| 2023-01-31 | Lloyd-Smith Malcolm Chief Integration Officer | Sale | −1,666 | $110.02 | $183K | 28,582 |
Page 48 of 49 · 963 trades